Titre : Syndromes parkinsoniens

Syndromes parkinsoniens : Questions médicales fréquentes

Termes MeSH sélectionnés :

Ventricular Function, Left
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Syndromes parkinsoniens : Questions médicales les plus fréquentes", "headline": "Syndromes parkinsoniens : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Syndromes parkinsoniens : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-25", "dateModified": "2025-04-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Syndromes parkinsoniens" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Troubles de la motricité", "url": "https://questionsmedicales.fr/mesh/D009069", "about": { "@type": "MedicalCondition", "name": "Troubles de la motricité", "code": { "@type": "MedicalCode", "code": "D009069", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.228.662" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Syndrome parkinsonien secondaire", "alternateName": "Parkinson Disease, Secondary", "url": "https://questionsmedicales.fr/mesh/D010302", "about": { "@type": "MedicalCondition", "name": "Syndrome parkinsonien secondaire", "code": { "@type": "MedicalCode", "code": "D010302", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.228.662.600.700" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Maladie de Parkinson post-encéphalitique", "alternateName": "Parkinson Disease, Postencephalitic", "url": "https://questionsmedicales.fr/mesh/D010301", "about": { "@type": "MedicalCondition", "name": "Maladie de Parkinson post-encéphalitique", "code": { "@type": "MedicalCode", "code": "D010301", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.228.662.600.700.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Syndromes parkinsoniens", "alternateName": "Parkinsonian Disorders", "code": { "@type": "MedicalCode", "code": "D020734", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sara Hall", "url": "https://questionsmedicales.fr/author/Sara%20Hall", "affiliation": { "@type": "Organization", "name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden." } }, { "@type": "Person", "name": "Shorena Janelidze", "url": "https://questionsmedicales.fr/author/Shorena%20Janelidze", "affiliation": { "@type": "Organization", "name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden." } }, { "@type": "Person", "name": "Oskar Hansson", "url": "https://questionsmedicales.fr/author/Oskar%20Hansson", "affiliation": { "@type": "Organization", "name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden." } }, { "@type": "Person", "name": "Hash Brown Taha", "url": "https://questionsmedicales.fr/author/Hash%20Brown%20Taha", "affiliation": { "@type": "Organization", "name": "Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, CA, USA." } }, { "@type": "Person", "name": "Carlo Colosimo", "url": "https://questionsmedicales.fr/author/Carlo%20Colosimo", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Santa Maria University Hospital, Terni, Italy. Electronic address: carlo.colosimo@uniroma1.it." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy.", "datePublished": "2024-07-12", "url": "https://questionsmedicales.fr/article/38997620", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12872-024-04022-7" } }, { "@type": "ScholarlyArticle", "name": "Impact of right ventricular lead position on left ventricular functions and early remodeling in permanent single- and dual-chamber pacemakers.", "datePublished": "2022-09-21", "url": "https://questionsmedicales.fr/article/36129537", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00399-022-00896-2" } }, { "@type": "ScholarlyArticle", "name": "Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.", "datePublished": "2023-06-07", "url": "https://questionsmedicales.fr/article/37290663", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijcard.2023.05.048" } }, { "@type": "ScholarlyArticle", "name": "Relationship between arterial stiffness, left ventricular diastolic function, and renal function in chronic kidney disease.", "datePublished": "2023-09-03", "url": "https://questionsmedicales.fr/article/37661275", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12882-023-03308-w" } }, { "@type": "ScholarlyArticle", "name": "Assessment of subclinical left ventricular systolic dysfunction in patients with asymptomatic severe aortic stenosis with preserved left ventricular systolic function by three-dimensional speckle tracking echocardiography.", "datePublished": "2023-07-31", "url": "https://questionsmedicales.fr/article/37519280", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/echo.15662" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009422" }, { "@type": "ListItem", "position": 3, "name": "Maladies du système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002493" }, { "@type": "ListItem", "position": 4, "name": "Troubles de la motricité", "item": "https://questionsmedicales.fr/mesh/D009069" }, { "@type": "ListItem", "position": 5, "name": "Syndromes parkinsoniens", "item": "https://questionsmedicales.fr/mesh/D020734" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Syndromes parkinsoniens - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Syndromes parkinsoniens", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Syndromes parkinsoniens", "description": "Comment diagnostiquer un syndrome parkinsonien ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels sont les critères de diagnostic ?\nPeut-on confondre avec d'autres maladies ?\nQuel rôle joue l'historique médical ?", "url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Ventricular+Function,+Left&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Syndromes parkinsoniens", "description": "Quels sont les symptômes moteurs principaux ?\nQuels symptômes non moteurs sont fréquents ?\nComment évoluent les symptômes ?\nY a-t-il des symptômes précoces ?\nLes symptômes affectent-ils la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Ventricular+Function,+Left&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Syndromes parkinsoniens", "description": "Peut-on prévenir les syndromes parkinsoniens ?\nQuel rôle joue l'exercice physique ?\nL'alimentation influence-t-elle le risque ?\nY a-t-il des facteurs environnementaux à considérer ?\nLe stress a-t-il un impact ?", "url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Ventricular+Function,+Left&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Syndromes parkinsoniens", "description": "Quels sont les traitements médicamenteux ?\nLa chirurgie est-elle une option ?\nQuels sont les effets secondaires des médicaments ?\nY a-t-il des thérapies complémentaires ?\nComment gérer les symptômes non moteurs ?", "url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Ventricular+Function,+Left&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Syndromes parkinsoniens", "description": "Quelles sont les complications courantes ?\nComment les chutes affectent-elles les patients ?\nLes troubles cognitifs sont-ils fréquents ?\nQuelles sont les complications psychologiques ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Ventricular+Function,+Left&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Syndromes parkinsoniens", "description": "Quels sont les principaux facteurs de risque ?\nLe sexe influence-t-il le risque ?\nLes traumatismes crâniens sont-ils un facteur ?\nL'exposition professionnelle joue-t-elle un rôle ?\nY a-t-il des liens avec d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Ventricular+Function,+Left&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un syndrome parkinsonien ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et l'évaluation des symptômes moteurs et non moteurs." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'imagerie comme l'IRM et des évaluations neuropsychologiques peuvent être réalisés." } }, { "@type": "Question", "name": "Quels sont les critères de diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent la bradykinésie, la rigidité et les tremblements au repos." } }, { "@type": "Question", "name": "Peut-on confondre avec d'autres maladies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la maladie de Wilson ou des syndromes atypiques peuvent être confondues." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier des facteurs de risque et des symptômes précurseurs." } }, { "@type": "Question", "name": "Quels sont les symptômes moteurs principaux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes moteurs incluent la bradykinésie, la rigidité, et les tremblements." } }, { "@type": "Question", "name": "Quels symptômes non moteurs sont fréquents ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes non moteurs incluent la dépression, l'anxiété et les troubles du sommeil." } }, { "@type": "Question", "name": "Comment évoluent les symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes évoluent progressivement, souvent en s'aggravant avec le temps." } }, { "@type": "Question", "name": "Y a-t-il des symptômes précoces ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la perte de l'odorat ou des troubles du sommeil peuvent apparaître tôt." } }, { "@type": "Question", "name": "Les symptômes affectent-ils la qualité de vie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent considérablement réduire la qualité de vie des patients." } }, { "@type": "Question", "name": "Peut-on prévenir les syndromes parkinsoniens ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention garantie, mais un mode de vie sain peut aider." } }, { "@type": "Question", "name": "Quel rôle joue l'exercice physique ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier peut améliorer la santé neurologique et retarder l'apparition des symptômes." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants peut réduire le risque de développer la maladie." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à considérer ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certains pesticides et toxines peut augmenter le risque de Parkinson." } }, { "@type": "Question", "name": "Le stress a-t-il un impact ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut aggraver les symptômes et influencer la progression de la maladie." } }, { "@type": "Question", "name": "Quels sont les traitements médicamenteux ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la lévodopa, les agonistes de la dopamine et les inhibiteurs de la COMT." } }, { "@type": "Question", "name": "La chirurgie est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la stimulation cérébrale profonde peut être envisagée pour certains patients." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des médicaments ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des mouvements involontaires." } }, { "@type": "Question", "name": "Y a-t-il des thérapies complémentaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie et l'ergothérapie peuvent aider à améliorer la fonction motrice." } }, { "@type": "Question", "name": "Comment gérer les symptômes non moteurs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements psychologiques et des médicaments peuvent aider à gérer les symptômes non moteurs." } }, { "@type": "Question", "name": "Quelles sont les complications courantes ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent les chutes, les troubles de la déglutition et les infections." } }, { "@type": "Question", "name": "Comment les chutes affectent-elles les patients ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les chutes peuvent entraîner des blessures graves, comme des fractures, et réduire l'autonomie." } }, { "@type": "Question", "name": "Les troubles cognitifs sont-ils fréquents ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreux patients développent des troubles cognitifs ou démence au cours de la maladie." } }, { "@type": "Question", "name": "Quelles sont les complications psychologiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les patients peuvent souffrir de dépression, d'anxiété et d'isolement social." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une approche multidisciplinaire est essentielle pour gérer les complications efficacement." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge avancé, les antécédents familiaux et l'exposition à des toxines." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les hommes sont généralement plus susceptibles de développer des syndromes parkinsoniens." } }, { "@type": "Question", "name": "Les traumatismes crâniens sont-ils un facteur ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traumatismes crâniens répétés peuvent augmenter le risque de développer la maladie." } }, { "@type": "Question", "name": "L'exposition professionnelle joue-t-elle un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines professions exposant à des produits chimiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Y a-t-il des liens avec d'autres maladies ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies auto-immunes et métaboliques peuvent être associées à un risque accru." } } ] } ] }

Sources (10000 au total)

Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy.

Sodium-glucose co-transporter 2 (SGLT2) inhibitors have beneficial effects in heart failure (HF), including reverse remodelling, but the mechanisms by which these benefits are conferred are unclear. I... We measured C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), interleukin 6 (IL-6), and interleukin 10 (IL-10) and neutrophil-to-lymphocyte ratio (NLR) in plasma s... Following 12 months of treatment dapagliflozin significantly reduced CRP compared to placebo (mean difference of -1.96; 95% CI -3.68 to -0.24, p = 0.026). There were no significant statistical changes... Dapagliflozin caused a significant reduction in CRP compared to placebo. There were correlations between reductions in inflammatory markers including IL-1β and improvements in global longitudinal stra... Clinicaltrials.gov NCT02956811 (06/11/2016)....

Impact of right ventricular lead position on left ventricular functions and early remodeling in permanent single- and dual-chamber pacemakers.

Right ventricular (RV) apical pacing can induce both interventricular dyssynchrony and intraventricular dyssynchrony. Mechanical dyssynchrony after long-term RV apical pacing is associated with reduce... We aimed to identify the short-term effects of the pacemaker RV lead position on remodeling of LV systolic functions.... The study included 30 patients who presented with an indication of permanent pacing and who underwent permanent single- or dual-chamber pacemaker insertion: 15 patients with RV apical pacing (RV apex)... At the 3‑month follow-up, post-pacing 2D speckle tracking echocardiography revealed impairment of global longitudinal strain in all patients and intraventricular dyssynchrony was significantly increas... In the short-term follow-up, 2D speckle tracking echocardiography showed more radial dyssynchrony in the apical location than in the non-apical location of RV lead. The RV septal pacing is a better al...

Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.

The use of Impella support is increasingly adopted to "protect" patients with severe coronary artery disease (CAD) and left ventricle (LV) dysfunction undergoing percutaneous coronary intervention (PC... To evaluate the impact of Impella-protected (Abiomed, Danvers, Massachusetts, USA) PCIs on myocardial function recovery.... Patients with significant LV dysfunction undergoing multi-vessel PCIs with pre-intervention Impella implantation were evaluated by echocardiography before PCI and at median follow up of 6 months: glob... A total of 48 high surgical risk (mean EuroSCORE II 8) patients with median LVEF value of 30%, extensive wall motion abnormalities (median WMSI 2.16), and severe multi-vessel CAD (mean SYNTAX score 35... In patients with extensive CAD and severe LV dysfunction, multi-vessel Impella-protected PCI was associated to an appreciable contractile recovery, mainly determined by regional wall motion improvemen...

Relationship between arterial stiffness, left ventricular diastolic function, and renal function in chronic kidney disease.

In chronic kidney disease, IgA nephropathy, and left ventricular diastolic dysfunction have prognostic significance as well. However, the relationship between diastolic dysfunction, arterial stiffness... 79 IgA nephropathy patients (aged 46 ± 11 years) and 50 controls were investigated. Tissue Doppler imaging was used to measure early (Ea) and late (Aa) diastolic velocities. Arterial stiffness was mea... We compared the IgAN patients to a similar cardiovascular risk group with a preserved eGFR. A strong correlation was found between Ea/Aa and SI (p < 0.001), also with PWVao (p < 0.001), just in IgAN, ... In chronic kidney disease, increased cardiac rigidity and vascular stiffness coexist with decreased renal function, which is directly connected to diastolic dysfunction and vascular stiffness. On the ...

Assessment of subclinical left ventricular systolic dysfunction in patients with asymptomatic severe aortic stenosis with preserved left ventricular systolic function by three-dimensional speckle tracking echocardiography.

Left ventricular dysfunction and remodeling can occur as a result of aortic valve stenosis (AS). Three-dimensional speckle tracking echocardiography (3D-STE) can detect early left ventricular myocardi... This study included 46 patients with asymptomatic severe AS but preserved LV systolic function (mean age 50.11 ± 12.66 years, LVEF 63.78 ± 3.95%, AS group) and 33 healthy subjects with no cardiovascul... The AS group had significantly thicker interventricular septum and posterior ventricular wall than the control group (1.49 ± .19 cm vs. .81 ± .09 cm, p < .001; 1.73 ± 1.71 cm vs. .81 ± .10 cm, p = .00... Our findings showed reductions in left ventricular global myocardial strains, particularly PSLS in patients suffering from asymptomatic severe AS in Bangladesh; this is consistent with other studies. ...

Left atrial strain parameters derived by echocardiography are impaired in patients with acute myocarditis and preserved systolic left ventricular function.

Data derived by cardiac magnetic resonance (CMR) feature tracking suggest that not only left ventricular but also left atrial function is impaired in patients with acute myocarditis. Therefore, we inv... 30 patients with acute myocarditis confirmed by CMR according to the Lake Louise criteria and 20 healthy controls were analyzed including global longitudinal strain (GLS) and left atrial (LA) strain p... In patients with acute myocarditis and preserved LVEF not only GLS but also LA reservoir function, LA conduit function and left atrial stiffness index as well as left atrial filling index were impaire...

The Use of Global Longitudinal Strain to Detect Subclinical Reduction in Left Ventricular Pump Function.

Left ventricular (LV) ejection fraction (LVEF) is not a sensitive marker of LV systolic function in a subset of patients with preserved EF. The relation between LV pump function and global longitudina... In total, 100 participants with LVEF of ≥50% were studied for demographic and echocardiographic data, including LVEF, stroke volume, SVI, COP, LV longitudinal strain assessments, apical 4-, 3-, and 2-... Reduced LV GLS was associated with lower SVI (35.6 ± 13.6 vs. 43.8 ± 12.7 mL/m 2 ; P = 0.01), lesser COP (5.4 ± 1.9 vs. 6.5 ± 2.1 l/min; P = 0.02), GLS had strong positive correlations with SVI ( r = ... Impaired LV strain is associated with lower LV pump function, presented as lower COP and lower SVI in patients with preserved EF even in the absence of clinical HF. It is of great importance to incorp...

Atrial paced rhythm and heart rate-dependent worsening of left atrial and ventricular function.

The response to the increase in heart rate (HR) could be characterized by failure in both left ventricular (LV) and left atrial (LA) functions. This study aimed to evaluate the relationship between th... In a group of patients with an implantable cardioverter defibrillator (ICD) or pacemaker, the atrial paced rhythm was progressively increased from 60 to 70, from 70 to 80, and from 80 to 90 beats per ... Of the 45 patients enrolled, a significant reduction in LAr was observed at higher HR. However, when the patients were dichotomized according to the HR-related response of LV-GLS, the worsening of LAr... In patients with atrial paced rhythm, the increase in HR could be associated with worsening of LA and LV functions, as assessed by two-dimensional speckle tracking analyses. These results offer new da...